|
⚲
|
| Keyboard |
| Cross John Harry III
✚
|
|
|---|---|
| CIK # | 0001806763 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001806763] | |
| 4 | [0001806763] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Cross John Harry III | |
| Senti Biosciences Holdings Inc | |
| Sonnet BioTherapeutics Holdings Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Senti Biosciences Holdings Inc SNTI
Stock Option (Right to Buy) · derivative
|
2025-03-07 | Grant | 174,200 | $0.00 | |
|
Sonnet BioTherapeutics Holdings Inc SONN
Common Stock
|
2023-12-11 | Grant | 1,452 | ||
|
Sonnet BioTherapeutics Holdings Inc SONN
Common Stock
|
2023-02-06 | Tax withheld | 1,960 | $1.06 | 2,078 |
|
Sonnet BioTherapeutics Holdings Inc SONN
Common Stock
|
2022-12-14 | Grant | 15,519 | ||
|
Sonnet BioTherapeutics Holdings Inc SONN
Common Stock
|
2021-12-15 | Grant | 66,951 | ||
|
Sonnet BioTherapeutics Holdings Inc SONN
Common Stock
|
2020-07-02 | Grant | 78,214 | $0.00 |